| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5587150 | LOREAL USA | Photostable cosmetic screening composition containing a UV-A screening agent and an alkyl β, β-diphenylacrylate or α-cyano-β,β-diphenylacrylate |
Dec, 2013
(10 years ago) | |
Anthelios Sx is owned by Loreal Usa.
Anthelios Sx contains Avobenzone; Ecamsule; Octocrylene.
Anthelios Sx has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Anthelios Sx are:
- US5587150
Anthelios Sx was authorised for market use on 21 July, 2006.
Anthelios Sx is available in cream;topical dosage forms.
Anthelios Sx can be used as sunscreen.
The generics of Anthelios Sx are possible to be released after 24 December, 2013.
Drugs and Companies using AVOBENZONE; ECAMSULE; OCTOCRYLENE ingredient
Market Authorisation Date: 21 July, 2006
Treatment: Sunscreen
Dosage: CREAM;TOPICAL
More Information on Dosage
ANTHELIOS SX family patents
